The Department of Neurology runs a large number of clinical trials in nearly every subspecialty of neurology. Below is a list of the department’s current clinical trials.
About participating
What is a clinical trial? Clinical trials are organized experiments performed on human participants to determine the best way to treat, diagnose or prevent a disease. The information that scientists learn from clinical trials helps to improve the medical care for future patients. Clinical studies are carefully and ethically designed to protect participants from unnecessary side effects and other risks. Most clinical research is federally regulated with built-in safeguards to protect the participants.
Active clinical trials
- Conditions: Alzheimers Disease; Dementia; Alzheimers Disease, Familial Interventions: Drug: Gantenerumab; Drug: Matching Placebo (Gantenerumab) Sponsors: Washington University School of Medicine; Hoffmann-La Roche; Alzheimer's Association; National Institute on Aging (NIA); Genentech, Inc. Suspended
- Conditions: Alzheimer Disease Interventions: Drug: 18F-Flortaucipir radiopharmaceutical; Drug: 18F-MK-6240 radiopharmaceutical; Drug: Amyloid-β radiopharmaceutical (11C-PiB or 18F-Florbetaben or 18F-NAV-4694) Sponsors: Tharick Pascoal; National Institute on Aging (NIA) Recruiting
- Conditions: Alzheimers Disease; Dementia; Alzheimers Disease, Familial Interventions: Drug: E2814; Drug: Lecanemab; Drug: Matching Placebo (E2814) Sponsors: Washington University School of Medicine; Alzheimer's Association; National Institute on Aging (NIA); Accelerating Medicines Partnership (AMP); Eisai Inc. Recruiting
- Conditions: Alzheimer Disease; Obesity; Metabolic Disease Sponsors: Cyrus A Raji Recruiting
- Conditions: Alzheimer Disease; Dementia of Alzheimer Type Interventions: Other: Arm A , Arm B, Arm C, & Arm D Sponsors: Washington University School of Medicine Enrolling by invitation
- Conditions: Alzheimer Disease Interventions: Drug: GV-971; Drug: Placebo Sponsors: Green Valley (Shanghai) Pharmaceuticals Co., Ltd. Suspended
- Conditions: Frontotemporal Dementia; Frontotemporal Lobar Degeneration; FTD-GRN Sponsors: The Bluefield Project to Cure Frontotemporal Dementia; Mayo Clinic; University of California, San Francisco Recruiting
- Conditions: Cognitive Impairment, Mild; Dementia; Cardiovascular Diseases Interventions: Drug: Atorvastatin 40 Mg Oral Tablet; Drug: Placebo oral tablet Sponsors: Duke University; National Institute on Aging (NIA); National Heart, Lung, and Blood Institute (NHLBI); Wake Forest University Health Sciences Recruiting
- Conditions: Alzheimers Disease; Dementia; Alzheimers Disease, Familial Interventions: Drug: Gantenerumab; Drug: Solanezumab; Drug: Matching Placebo (Gantenerumab); Drug: Matching Placebo (Solanezumab); Drug: Gantenerumab; Drug: E2814; Drug: Lecanemab; Drug: Matching Placebo (E2814) Sponsors: Washington University School of Medicine; Eli Lilly and Company; Hoffmann-La Roche; Alzheimer's Association; National Institute on Aging (NIA); Avid Radiopharmaceuticals; Accelerating Medicines Partnership (AMP); Eisai Inc.; Janssen, LP Recruiting
- Conditions: Huntington's Disease Sponsors: CHDI Foundation, Inc. Recruiting
- Conditions: Alzheimer's Disease Sponsors: Washington University School of Medicine; National Institute on Aging (NIA) Recruiting
For a more comprehensive list of our Alzheimer disease clinical trials, please visit the Knight ADRC website, the Knight ADRC Clinical Trials Unit website and DIAN website.
- Conditions: Tuberous Sclerosis Complex Interventions: Drug: Vigabatrin; Drug: Placebo Sponsors: Martina Bebin; National Institute of Neurological Disorders and Stroke (NINDS) Completed
- Conditions: Parkinson Disease; Multiple System Atrophy, Parkinson Variant; Progressive Supranuclear Palsy Interventions: Diagnostic Test: AIDP Sponsors: University of Florida; Augusta University; Albany Medical College; Beth Israel Deaconess Medical Center; Duke University; Johns Hopkins University; Massachusetts General Hospital; Northwestern University; Ottawa Hospital Research Institute; Penn State University; University of Alabama at Birmingham; University of California, San Diego; University of California, San Francisco; University of Chicago; University of Michigan; University of Minnesota; University of South Florida; Centre for Addiction and Mental Health; Wake Forest University; Washington University School of Medicine; University of Kentucky; National Institute of Neurological Disorders and Stroke (NINDS) Recruiting
- Conditions: Primary Ciliary Dyskinesia; Kartagener Syndrome Sponsors: University of North Carolina, Chapel Hill; Washington University School of Medicine; Children's Hospital Colorado; Stanford University; Seattle Children's Hospital; The Hospital for Sick Children; McGill University; Children's Hospital Medical Center, Cincinnati Recruiting
- Conditions: Primary Ciliary Dyskinesia; Kartagener Syndrome; Primary Immune Deficiency Sponsors: University of North Carolina, Chapel Hill; Washington University School of Medicine; The Hospital for Sick Children; McGill University; Children's Hospital Medical Center, Cincinnati; National Heart, Lung, and Blood Institute (NHLBI) Recruiting
- Conditions: Primary Ciliary Dyskinesia; Primary Immune Deficiency; Kartagener Syndrome Interventions: Diagnostic Test: Genetic Testing for PCD or PID; Other: Unaffected Family Member Genetic Testing Sponsors: University of North Carolina, Chapel Hill; Washington University School of Medicine; National Heart, Lung, and Blood Institute (NHLBI); Children's Hospital Colorado; Stanford University; Seattle Children's Hospital; The Hospital for Sick Children; McGill University; Children's Hospital Medical Center, Cincinnati Recruiting
- Conditions: Parkinson Disease; Sleep Disorder; Fatigue Interventions: Device: SunRay Light Boxes Sponsors: Massachusetts General Hospital Active, not recruiting
- Conditions: Parkinson Disease Interventions: Behavioral: Physical Therapy Sponsors: Washington University School of Medicine; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Completed
- Conditions: Huntington's Disease Sponsors: CHDI Foundation, Inc. Recruiting
- Conditions: Multiple Sclerosis; Depression Interventions: Other: Neuro-QoL T-score determination Sponsors: Washington University School of Medicine; University of Connecticut; University of Texas Recruiting
- Conditions: Tuberous Sclerosis; Lymphangioleiomyomatosis Interventions: Procedure: Phlebotomy; Procedure: Buccal (cheek) swab; Genetic: Genetic Testing; Other: Tissue donation after routine clinical procedure Sponsors: National Tuberous Sclerosis Association Recruiting
- Conditions: Multiple Sclerosis Interventions: Diagnostic Test: MRI Sponsors: The Cleveland Clinic; National Institutes of Health (NIH); National Institute of Neurological Disorders and Stroke (NINDS); University of Pennsylvania; Cedars-Sinai Medical Center Active, not recruiting
- Conditions: Multiple Sclerosis Interventions: Device: SOMAscan Sponsors: Washington University School of Medicine; National Institute of Allergy and Infectious Diseases (NIAID); University of Colorado, Denver; University of Ottawa; Montana State University Active, not recruiting
- Conditions: Primary Progressive Multiple Sclerosis; Secondary Progressive Multiple Sclerosis Interventions: Biological: ATA188; Drug: Placebo Sponsors: Atara Biotherapeutics Active, not recruiting
- Conditions: Tuberous Sclerosis Complex Interventions: Drug: Vigabatrin; Drug: Placebo Sponsors: Martina Bebin; National Institute of Neurological Disorders and Stroke (NINDS) Completed
- Conditions: Spinal and Bulbar Muscular Atrophy; Kennedy's Disease Interventions: Drug: AJ201; Drug: Placebo Sponsors: AnnJi Pharmaceutical Co., Ltd. Recruiting
- Conditions: Spinal Muscular Atrophy; Neuromuscular Diseases; SMA Interventions: Drug: taldefgrobep alfa; Drug: Placebo; Drug: taldefgrobep alfa Sponsors: Biohaven Pharmaceuticals, Inc. Recruiting
- Conditions: Spinal Muscular Atrophy Interventions: Drug: Risdiplam Sponsors: Genentech, Inc. Recruiting
- Conditions: Sporadic Inclusion Body Myositis; Inclusion Body Myositis Sponsors: University of California, Irvine; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Recruiting
- Conditions: Cubital Tunnel Syndrome; Nerve Compression; Nerve Injury; Ulnar Neuropathies Interventions: Device: Checkpoint BEST System Sponsors: Checkpoint Surgical Inc.; Congressionally Directed Medical Research Programs Recruiting
- Conditions: Muscular Dystrophy, Duchenne Interventions: Genetic: delandistrogene moxeparvovec Sponsors: Sarepta Therapeutics, Inc.; Hoffmann-La Roche Enrolling by invitation
- Conditions: Neuropathic Pain Interventions: Drug: Ondansetron 16 mg with Tariquidar; Drug: Ondansetron 16 mg with Placebo Sponsors: Washington University School of Medicine Recruiting
- Conditions: Cubital Tunnel Syndrome; Peroneal Nerve Entrapment Interventions: Device: Mechanomyography (MMG) Sponsors: Washington University School of Medicine; Mayo Clinic Active, not recruiting
- Conditions: Amyotrophic Lateral Sclerosis, Familial; Amyotrophic Lateral Sclerosis, Sporadic Sponsors: Washington University School of Medicine; Massachusetts General Hospital Suspended
- Conditions: Duchenne Muscular Dystrophy Interventions: Drug: Pamrevlumab Sponsors: FibroGen Active, not recruiting
- Conditions: Sarcoma; Malignant Peripheral Nerve Sheath Tumors Interventions: Drug: PLX3397; Drug: Sirolimus Sponsors: Gulam Manji; Daiichi Sankyo, Inc. Recruiting
An error has occurred, which probably means the feed is down. Try again later.
An error has occurred, which probably means the feed is down. Try again later.
- Conditions: Spinal and Bulbar Muscular Atrophy; Kennedy's Disease Interventions: Drug: AJ201; Drug: Placebo Sponsors: AnnJi Pharmaceutical Co., Ltd. Recruiting
- Conditions: Spinal Muscular Atrophy; Neuromuscular Diseases; SMA Interventions: Drug: taldefgrobep alfa; Drug: Placebo; Drug: taldefgrobep alfa Sponsors: Biohaven Pharmaceuticals, Inc. Recruiting
- Conditions: Spinal Muscular Atrophy Interventions: Drug: Risdiplam Sponsors: Genentech, Inc. Recruiting
- Conditions: Muscular Dystrophy, Duchenne Interventions: Genetic: delandistrogene moxeparvovec Sponsors: Sarepta Therapeutics, Inc.; Hoffmann-La Roche Enrolling by invitation
- Conditions: Duchenne Muscular Dystrophy Interventions: Drug: Pamrevlumab Sponsors: FibroGen Active, not recruiting
- Conditions: Treatment Resistant Depression Interventions: Diagnostic Test: Electroencephalography (EEG); Diagnostic Test: Quantitative Measurements of Sleep Microstructure Sponsors: Washington University School of Medicine; National Institute of Mental Health (NIMH) Recruiting
- Conditions: Parkinson Disease; Sleep Disorder; Fatigue Interventions: Device: SunRay Light Boxes Sponsors: Massachusetts General Hospital Active, not recruiting
- Conditions: Obstructive Sleep Apnea; Tonsillitis Interventions: Drug: Hydromorphone; Drug: Fentanyl Sponsors: Washington University School of Medicine Completed
- Conditions: Sleep; Sedation Complication Interventions: Radiation: MRI; Diagnostic Test: Quantitative Sensory Testing (QST); Diagnostic Test: Home sleep study; Other: Acoustic stimulation (65db) up-slope of EEG with QST; Other: Acoustic stimulation (65db) down-slope of EEG with QST; Other: 0 db with QST; Drug: Dexmedetomidine; Other: Breathe-Squeeze Task Sponsors: Washington University School of Medicine Active, not recruiting
- Conditions: Obstructive Sleep Apnea; Pregnancy Related; Insulin Sensitivity Interventions: Device: Continuous Positive Airway Pressure Sponsors: Barnes-Jewish Hospital; Washington University School of Medicine Withdrawn
- Conditions: Ischemic Stroke; Sleep Apnea; Sleep Apnea, Obstructive; TIA; Stroke; CPAP; Telemedicine; Home Sleep Apnea Test; Randomized Clinical Trial; Multicenter Trial Interventions: Device: CPAP Sponsors: University of Michigan; National Institute of Neurological Disorders and Stroke (NINDS); FusionHealth LLC; Medical University of South Carolina; University of Cincinnati Recruiting
- Conditions: Heart Failure; Central Sleep Apnea Interventions: Drug: Oxygen; Other: Room Air Sponsors: Brigham and Women's Hospital; Ohio State University Terminated
- Conditions: Heart Failure; Defibrillators, Implantable; Monitoring, Physiologic; Cardiac Resynchronization Therapy; Cardiovascular Disease; Heart Disease Interventions: Device: HeartLogic Sensors Sponsors: Boston Scientific Corporation Completed
- Conditions: Postoperative Delirium Sponsors: Washington University School of Medicine Active, not recruiting
- Conditions: Mild Cognitive Impairment; Sleep Apnea, Obstructive Interventions: Device: CPAP Sponsors: University of Pennsylvania; National Institute on Aging (NIA) Active, not recruiting
- Conditions: Student Wellness Interventions: Behavioral: RefreshMD; Behavioral: Bond Between Us Sponsors: Stanford University Completed
- Conditions: Carotid Atherosclerosis; Asymptomatic Carotid Artery Stenosis; Carotid Artery Atheroma Interventions: Drug: 64Cu-25%-CANF-Comb; Drug: 64Cu-25%-CANF-Comb Sponsors: Washington University School of Medicine; Cedars-Sinai Medical Center; University of California, Santa Barbara; National Heart, Lung, and Blood Institute (NHLBI) Recruiting
- Conditions: Prevention of Ischemic Stroke; Acute Non-cardioembolic Ischemic Stroke; High-risk Transient Ischemic Attack Interventions: Drug: Asundexian (BAY2433334); Drug: Placebo Sponsors: Bayer Recruiting
- Conditions: Intra Cerebral Hemorrhage; ICH – Intracerebral Hemorrhage; ICH; Hemorrhage; Stroke; Clot (Blood); Brain; Clot Blood; Cognitive Decline; Cognitive Impairment; Survivorship; Memory Impairment; Motor Activity Sponsors: Johns Hopkins University; National Institute of Neurological Disorders and Stroke (NINDS) Enrolling by invitation
- Conditions: Acute Ischemic Stroke Interventions: Device: transcutaneous auricular vagal nerve stimulation; Device: Sham transcutaneous vagal nerve stimulation Sponsors: Washington University School of Medicine Recruiting
- Conditions: Sickle Cell Disease Interventions: Other: Crizanlizumab Sponsors: Andria Ford; Novartis Pharmaceuticals Recruiting
- Conditions: Intracranial Arteriosclerosis; Stroke Interventions: Drug: Ticagrelor + Aspirin; Drug: Rivaroxaban + Aspirin; Drug: Clopidogrel + Aspirin; Other: Risk Factor Management Sponsors: University of Florida; National Institute of Neurological Disorders and Stroke (NINDS); University of Cincinnati; Medical University of South Carolina; Janssen Scientific Affairs, LLC; AstraZeneca Recruiting
- Conditions: Stroke; Thromboses, Intracranial; Aneurysm, Brain Interventions: Procedure: Stroke/Thrombectomy/Aneurysm-specific surgical procedures Sponsors: Medical University of South Carolina Recruiting
- Conditions: Supratentorial Hemorrhage Interventions: Device: Aurora Surgiscope System Sponsors: Integra LifeSciences Corporation; Icahn School of Medicine at Mount Sinai; Oculus Imaging LLC Recruiting
- Conditions: Subdural Hematoma Interventions: Procedure: Surgical Management; Device: Surgical Management + Treatment; Other: No Treatment; Device: Treatment Sponsors: Medtronic Neurovascular Clinical Affairs Recruiting
- Conditions: Intracerebral Hemorrhage Interventions: Drug: Statins Sponsors: Beth Israel Deaconess Medical Center; NINDS Stroke Trials Network (StrokeNet); Canadian Stroke Consortium (CSC); University of Cincinnati; Medical University of South Carolina; Yale University; MetroHealth Medical Center; UH, Cleveland Medical Center; Spectrum Health Hospitals; West Virginia University; Columbia University; Weill Medical College of Cornell University; New York Presbyterian Brooklyn Methodist Hospital; Buffalo General Medical Center; State University of New York – Upstate Medical University; St. Joseph's Regional Medical Center, New Jersey; Tufts Medical Center; Massachusetts General Hospital; UMASS Memorial Medical Center; Brigham and Women's Hospital; Baystate Medical Center; University of Vermont Medical Center; […]
- Conditions: Intracerebral Hemorrhage; Atrial Fibrillation Interventions: Drug: Apixaban; Drug: Aspirin Sponsors: Yale University; National Institute of Neurological Disorders and Stroke (NINDS) Recruiting
- Conditions: Ischemic Stroke; Sleep Apnea; Sleep Apnea, Obstructive; TIA; Stroke; CPAP; Telemedicine; Home Sleep Apnea Test; Randomized Clinical Trial; Multicenter Trial Interventions: Device: CPAP Sponsors: University of Michigan; National Institute of Neurological Disorders and Stroke (NINDS); FusionHealth LLC; Medical University of South Carolina; University of Cincinnati Recruiting
- Conditions: Acute Ischemic Stroke Interventions: Drug: Argatroban; Drug: Eptifibatide; Drug: Placebo Sponsors: Washington University School of Medicine; National Institute of Neurological Disorders and Stroke (NINDS) Active, not recruiting
- Conditions: Cerebral Stroke Interventions: Device: EmboTrap® Revascularization Device; Device: CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter Sponsors: Cerenovus, Part of DePuy Synthes Products, Inc. Recruiting
- Conditions: Intracerebral Hemorrhage Interventions: Biological: Recombinant Activated Factor VII (rFVIIa); Biological: Placebo Sponsors: Joseph Broderick, MD; Novo Nordisk A/S; National Institute of Neurological Disorders and Stroke (NINDS) Recruiting
- Conditions: Stroke Interventions: Drug: Apixaban; Drug: Aspirin Sponsors: Columbia University; National Institute of Neurological Disorders and Stroke (NINDS); University of Cincinnati; Medical University of South Carolina; Bristol-Myers Squibb; Pfizer; Roche Pharma AG; Weill Medical College of Cornell University; University of Washington Terminated
A patient’s story
Seeking a cure for future ALS patients — “I care, and I want to help.”